Wildman S S, Brown S G, King B F, Burnstock G
Autonomic Neuroscience Institute, Royal Free Hospital School of Medicine, Hampstead, London, UK.
Eur J Pharmacol. 1999 Feb 12;367(1):119-23. doi: 10.1016/s0014-2999(98)00976-5.
The pharmacological activity of diadenosine polyphosphates was investigated at three recombinant P2X receptors (rat P2X1, rat P2X3, rat P2X4) expressed in Xenopus oocytes and studied under voltage-clamp conditions. For the rat P2X1 receptor, only P1,P6-diadenosine hexaphosphate (Ap6A) was a full agonist yet 2-3 folds less potent than ATP. At rat P2X3, P1,p4-diadenosine tetraphosphate (Ap4A), P1,P5-diadenosine pentaphosphate (Ap5A) and Ap6A were full agonists and more potent than ATP. Ap4A alone was equipotent with ATP at rat P2X4, but only as a partial agonist. Compared to known data for rat P2X2 and human P2X1 receptors, our findings contrast with rat P2X2 where only Ap4A is a full agonist although four folds less potent than ATP. At rat and human orthologues of P2X1, Ap5A was a partial agonist with similar potency. These data provide a useful basis for selective agonists of P2X receptor subunits.
在非洲爪蟾卵母细胞中表达的三种重组P2X受体(大鼠P2X1、大鼠P2X3、大鼠P2X4)上研究了二腺苷多磷酸的药理活性,并在电压钳条件下进行了研究。对于大鼠P2X1受体,只有P1,P6 - 二腺苷六磷酸(Ap6A)是完全激动剂,但其效力比ATP低2 - 3倍。在大鼠P2X3上,P1,p4 - 二腺苷四磷酸(Ap4A)、P1,P5 - 二腺苷五磷酸(Ap5A)和Ap6A是完全激动剂,且比ATP更有效。单独的Ap4A在大鼠P2X4上与ATP等效,但只是部分激动剂。与大鼠P2X2和人P2X1受体的已知数据相比,我们的发现与大鼠P2X2不同,在大鼠P2X2中只有Ap4A是完全激动剂,尽管其效力比ATP低四倍。在大鼠和人P2X1的直系同源物上,Ap5A是具有相似效力的部分激动剂。这些数据为P2X受体亚基的选择性激动剂提供了有用的基础。